Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05634733

Change in MAPSE During Treatment of Sepsis

Evaluation of Mitral Annulus Systolic Plane Excursion (MAPSE) in Emergency Department Patients With Sepsis

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with bloodstream infections (sepsis) have been found in prior studies to have infection-related heart dysfunction, even if they did not have preexisting heart problems. Factors related to the infection may cause the heart to not pump as well as it should, causing critical illness in the form of low blood pressure (shock) and heart failure. Ultrasound is frequently used in the emergency department to evaluate why a patient might have low blood pressure. Part of that evaluation may include obtaining ultrasound images and making measurements about how well or poorly the heart is pumping. The investigators will evaluate a certain measurement that relates to cardiac function, determine how it changes in patients before and after they are treated for septic shock. This will involve placing an ultrasound probe on the patient's chest, measuring the upward and downward movement of the mitral valve, the mitral annulus systolic plane excursion (MAPSE), and comparing the measurements before and after treatment is started. The investigators are attempting to determine if this measurement improves before and after treatment.

Conditions

Interventions

TypeNameDescription
OTHERTreatment of SepsisPatients will have standard care of sepsis

Timeline

Start date
2023-04-01
Primary completion
2030-04-01
Completion
2030-12-01
First posted
2022-12-02
Last updated
2025-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05634733. Inclusion in this directory is not an endorsement.